Skip to main content
Erschienen in: Heart Failure Reviews 1/2013

01.01.2013

Assessment and management of aortic valve disease in patients with left ventricular dysfunction

verfasst von: Mackram F. Eleid, Sunil Mankad, Paul Sorajja

Erschienen in: Heart Failure Reviews | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The onset of symptoms or left ventricular systolic dysfunction heralds a poor prognosis for patients with either aortic stenosis or aortic regurgitation. Echocardiography is the primary imaging modality for assessment of aortic valvular lesions. Cardiac catheterization is indicated to determine the severity of the aortic valve lesion when there is a discrepancy between the clinical findings and the results of echocardiography in patients with either symptoms or left ventricular dysfunction. For patients with low-gradient, low-output aortic stenosis, dobutamine provocation should be used to differentiate truly severe aortic stenosis from patients with a primary cardiomyopathy and low aortic valve area due to low forward flow. Aortic valve surgery improves myocardial performance by relief of ventricular afterload in both patients with severe stenosis and those with severe regurgitation. Surgery should be pursued in both patients with severe aortic stenosis and those with severe regurgitation regardless of the degree of left ventricular dysfunction.
Literatur
1.
Zurück zum Zitat Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011PubMedCrossRef Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011PubMedCrossRef
2.
Zurück zum Zitat Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB (1976) Adaptations of the left ventricle to chronic pressure overload. Circ Res 38(3):172–178PubMedCrossRef Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB (1976) Adaptations of the left ventricle to chronic pressure overload. Circ Res 38(3):172–178PubMedCrossRef
3.
Zurück zum Zitat Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM (1997) Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 95(4):892–898PubMedCrossRef Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM (1997) Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 95(4):892–898PubMedCrossRef
4.
Zurück zum Zitat Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107(7):984–991PubMedCrossRef Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107(7):984–991PubMedCrossRef
5.
Zurück zum Zitat Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336(16):1131–1141PubMedCrossRef Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336(16):1131–1141PubMedCrossRef
6.
Zurück zum Zitat Villari B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT, Krayenbuehl HP (1993) Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 22(5):1477–1484PubMedCrossRef Villari B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT, Krayenbuehl HP (1993) Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 22(5):1477–1484PubMedCrossRef
7.
Zurück zum Zitat Tsutsui H, Ishihara K, Cooper G (1993) Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science 260(5108):682–687PubMedCrossRef Tsutsui H, Ishihara K, Cooper G (1993) Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science 260(5108):682–687PubMedCrossRef
8.
Zurück zum Zitat Nakano K, Corin WJ, Spann JF Jr, Biederman RW, Denslow S, Carabello BA (1989) Abnormal subendocardial blood flow in pressure overload hypertrophy is associated with pacing-induced subendocardial dysfunction. Circ Res 65(6):1555–1564PubMedCrossRef Nakano K, Corin WJ, Spann JF Jr, Biederman RW, Denslow S, Carabello BA (1989) Abnormal subendocardial blood flow in pressure overload hypertrophy is associated with pacing-induced subendocardial dysfunction. Circ Res 65(6):1555–1564PubMedCrossRef
9.
Zurück zum Zitat Communal C, Singh K, Pimentel DR, Colucci WS (1998) Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98(13):1329–1334PubMedCrossRef Communal C, Singh K, Pimentel DR, Colucci WS (1998) Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98(13):1329–1334PubMedCrossRef
10.
Zurück zum Zitat Ito K, Yan X, Feng X, Manning WJ, Dillmann WH, Lorell BH (2001) Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure. Circ Res 89(5):422–429PubMedCrossRef Ito K, Yan X, Feng X, Manning WJ, Dillmann WH, Lorell BH (2001) Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure. Circ Res 89(5):422–429PubMedCrossRef
11.
Zurück zum Zitat Richards AM, Nicholls MG, Ikram H, Hamilton EJ, Richards RD (1984) Syncope in aortic valvular stenosis. Lancet 2(8412):1113–1116PubMedCrossRef Richards AM, Nicholls MG, Ikram H, Hamilton EJ, Richards RD (1984) Syncope in aortic valvular stenosis. Lancet 2(8412):1113–1116PubMedCrossRef
12.
Zurück zum Zitat Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP Jr, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5):e84–e231PubMedCrossRef Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP Jr, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5):e84–e231PubMedCrossRef
13.
Zurück zum Zitat Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Luderitz B, Schild H, Sommer T (2003) Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361(9365):1241–1246PubMedCrossRef Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Luderitz B, Schild H, Sommer T (2003) Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361(9365):1241–1246PubMedCrossRef
14.
Zurück zum Zitat Gorlin R, Gorlin SG (1951) Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 41(1):1–29PubMedCrossRef Gorlin R, Gorlin SG (1951) Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 41(1):1–29PubMedCrossRef
15.
Zurück zum Zitat Hakki AH, Iskandrian AS, Bemis CE, Kimbiris D, Mintz GS, Segal BL, Brice C (1981) A simplified valve formula for the calculation of stenotic cardiac valve areas. Circulation 63(5):1050–1055PubMedCrossRef Hakki AH, Iskandrian AS, Bemis CE, Kimbiris D, Mintz GS, Segal BL, Brice C (1981) A simplified valve formula for the calculation of stenotic cardiac valve areas. Circulation 63(5):1050–1055PubMedCrossRef
16.
Zurück zum Zitat Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F, Baumgartner H, Beanlands RS, Chayer B, Kadem L, Garcia D, Durand LG, Pibarot P (2006) Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 113(5):711–721PubMedCrossRef Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F, Baumgartner H, Beanlands RS, Chayer B, Kadem L, Garcia D, Durand LG, Pibarot P (2006) Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 113(5):711–721PubMedCrossRef
18.
Zurück zum Zitat Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr (2002) Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106(7):809–813PubMedCrossRef Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr (2002) Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106(7):809–813PubMedCrossRef
19.
Zurück zum Zitat deFilippi CR, Willett DL, Brickner ME, Appleton CP, Yancy CW, Eichhorn EJ, Grayburn PA (1995) Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75(2):191–194PubMedCrossRef deFilippi CR, Willett DL, Brickner ME, Appleton CP, Yancy CW, Eichhorn EJ, Grayburn PA (1995) Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75(2):191–194PubMedCrossRef
20.
Zurück zum Zitat Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, Pop C, Ohlmann P, Lelguen C, Dehant P, Tribouilloy C, Gueret P (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3):319–324PubMedCrossRef Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, Pop C, Ohlmann P, Lelguen C, Dehant P, Tribouilloy C, Gueret P (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3):319–324PubMedCrossRef
21.
Zurück zum Zitat Quere JP, Monin JL, Levy F, Petit H, Baleynaud S, Chauvel C, Pop C, Ohlmann P, Lelguen C, Dehant P, Gueret P, Tribouilloy C (2006) Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113(14):1738–1744PubMedCrossRef Quere JP, Monin JL, Levy F, Petit H, Baleynaud S, Chauvel C, Pop C, Ohlmann P, Lelguen C, Dehant P, Gueret P, Tribouilloy C (2006) Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113(14):1738–1744PubMedCrossRef
22.
Zurück zum Zitat Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P (2007) Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115(22):2856–2864PubMedCrossRef Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P (2007) Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115(22):2856–2864PubMedCrossRef
23.
Zurück zum Zitat Barasch E, Fan D, Chukwu EO, Han J, Passick M, Petillo F, Norales A, Reichek N (2008) Severe isolated aortic stenosis with normal left ventricular systolic function and low transvalvular gradients: pathophysiologic and prognostic insights. J Heart Valve Dis 17(1):81–88PubMed Barasch E, Fan D, Chukwu EO, Han J, Passick M, Petillo F, Norales A, Reichek N (2008) Severe isolated aortic stenosis with normal left ventricular systolic function and low transvalvular gradients: pathophysiologic and prognostic insights. J Heart Valve Dis 17(1):81–88PubMed
24.
Zurück zum Zitat Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Skjaerpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Barwolf C (2011) Outcome of patients with low-gradient “severe” aortic stenosis and preserved ejection fraction. Circulation 123(8):887–895PubMedCrossRef Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Skjaerpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Barwolf C (2011) Outcome of patients with low-gradient “severe” aortic stenosis and preserved ejection fraction. Circulation 123(8):887–895PubMedCrossRef
25.
Zurück zum Zitat Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, Stewart WJ, McCarthy PM, Thomas JD, Asher CR (2002) Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 39(8):1356–1363PubMedCrossRef Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, Stewart WJ, McCarthy PM, Thomas JD, Asher CR (2002) Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 39(8):1356–1363PubMedCrossRef
26.
Zurück zum Zitat Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ (1990) The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 15(5):1012–1017PubMedCrossRef Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ (1990) The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 15(5):1012–1017PubMedCrossRef
27.
Zurück zum Zitat Connolly HM, Oh JK, Schaff HV, Roger VL, Osborn SL, Hodge DO, Tajik AJ (2000) Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation 101(16):1940–1946PubMedCrossRef Connolly HM, Oh JK, Schaff HV, Roger VL, Osborn SL, Hodge DO, Tajik AJ (2000) Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation 101(16):1940–1946PubMedCrossRef
28.
Zurück zum Zitat Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607PubMedCrossRef Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607PubMedCrossRef
29.
Zurück zum Zitat Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308PubMedCrossRef Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308PubMedCrossRef
30.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198PubMedCrossRef Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198PubMedCrossRef
31.
Zurück zum Zitat Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A (2010) Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. J Am Coll Cardiol 3(11):1110–1121 Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A (2010) Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. J Am Coll Cardiol 3(11):1110–1121
32.
Zurück zum Zitat Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF (1994) The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 23(5):1071–1075PubMedCrossRef Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF (1994) The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 23(5):1071–1075PubMedCrossRef
33.
Zurück zum Zitat Ross J Jr (1976) Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 18(4):255–264PubMedCrossRef Ross J Jr (1976) Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 18(4):255–264PubMedCrossRef
34.
Zurück zum Zitat Ricci DR (1982) Afterload mismatch and preload reserve in chronic aortic regurgitation. Circulation 66(4):826–834PubMedCrossRef Ricci DR (1982) Afterload mismatch and preload reserve in chronic aortic regurgitation. Circulation 66(4):826–834PubMedCrossRef
35.
Zurück zum Zitat Borer JS, Truter S, Herrold EM, Falcone DJ, Pena M, Carter JN, Dumlao TF, Lee JA, Supino PG (2002) Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105(15):1837–1842PubMedCrossRef Borer JS, Truter S, Herrold EM, Falcone DJ, Pena M, Carter JN, Dumlao TF, Lee JA, Supino PG (2002) Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105(15):1837–1842PubMedCrossRef
36.
Zurück zum Zitat Liu SK, Magid NR, Fox PR, Goldfine SM, Borer JS (1998) Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology 90(2):101–109PubMedCrossRef Liu SK, Magid NR, Fox PR, Goldfine SM, Borer JS (1998) Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology 90(2):101–109PubMedCrossRef
37.
Zurück zum Zitat Devlin WH, Petrusha J, Briesmiester K, Montgomery D, Starling MR (1999) Impact of vascular adaptation to chronic aortic regurgitation on left ventricular performance. Circulation 99(8):1027–1033PubMedCrossRef Devlin WH, Petrusha J, Briesmiester K, Montgomery D, Starling MR (1999) Impact of vascular adaptation to chronic aortic regurgitation on left ventricular performance. Circulation 99(8):1027–1033PubMedCrossRef
38.
Zurück zum Zitat Borer JS, Hochreiter C, Herrold EM, Supino P, Aschermann M, Wencker D, Devereux RB, Roman MJ, Szulc M, Kligfield P, Isom OW (1998) Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 97(6):525–534PubMedCrossRef Borer JS, Hochreiter C, Herrold EM, Supino P, Aschermann M, Wencker D, Devereux RB, Roman MJ, Szulc M, Kligfield P, Isom OW (1998) Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 97(6):525–534PubMedCrossRef
39.
Zurück zum Zitat Bonow RO (2005) Aortic regurgitation. In: Zipes D (ed) Braunwald’s heart disease: a textbook of cardiovascular medicine, vol 2, 7th edn. WB Saunders, Philadelphia, pp 1553–1632 Bonow RO (2005) Aortic regurgitation. In: Zipes D (ed) Braunwald’s heart disease: a textbook of cardiovascular medicine, vol 2, 7th edn. WB Saunders, Philadelphia, pp 1553–1632
40.
Zurück zum Zitat Desjardins VA, Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB (1996) Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 100(2):149–156PubMedCrossRef Desjardins VA, Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB (1996) Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 100(2):149–156PubMedCrossRef
41.
Zurück zum Zitat Sellers RD, Levy MJ, Amplatz K, Lillehei CW (1964) Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am J Cardiol 14:437–447PubMedCrossRef Sellers RD, Levy MJ, Amplatz K, Lillehei CW (1964) Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am J Cardiol 14:437–447PubMedCrossRef
42.
Zurück zum Zitat Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB (1997) Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 30(3):746–752PubMedCrossRef Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB (1997) Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 30(3):746–752PubMedCrossRef
43.
Zurück zum Zitat Taniguchi K, Nakano S, Kawashima Y, Sakai K, Kawamoto T, Sakaki S, Kobayashi J, Morimoto S, Matsuda H (1990) Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 82(3):798–807PubMedCrossRef Taniguchi K, Nakano S, Kawashima Y, Sakai K, Kawamoto T, Sakaki S, Kobayashi J, Morimoto S, Matsuda H (1990) Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 82(3):798–807PubMedCrossRef
44.
Zurück zum Zitat Bonow RO, Rosing DR, Maron BJ, McIntosh CL, Jones M, Bacharach SL, Green MV, Clark RE, Epstein SE (1984) Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 70(4):570–579PubMedCrossRef Bonow RO, Rosing DR, Maron BJ, McIntosh CL, Jones M, Bacharach SL, Green MV, Clark RE, Epstein SE (1984) Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 70(4):570–579PubMedCrossRef
45.
Zurück zum Zitat Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, Enriquez-Sarano M (2002) Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 106(21):2687–2693PubMedCrossRef Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, Enriquez-Sarano M (2002) Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 106(21):2687–2693PubMedCrossRef
46.
Zurück zum Zitat Chukwuemeka A, Rao V, Armstrong S, Ivanov J, David T (2006) Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur J Cardiothorac Surg 29(2):133–138PubMedCrossRef Chukwuemeka A, Rao V, Armstrong S, Ivanov J, David T (2006) Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur J Cardiothorac Surg 29(2):133–138PubMedCrossRef
47.
Zurück zum Zitat Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S (1994) Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 331(11):689–694PubMedCrossRef Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S (1994) Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 331(11):689–694PubMedCrossRef
48.
Zurück zum Zitat Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler–Soler J (2005) Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 353(13):1342–1349PubMedCrossRef Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler–Soler J (2005) Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 353(13):1342–1349PubMedCrossRef
Metadaten
Titel
Assessment and management of aortic valve disease in patients with left ventricular dysfunction
verfasst von
Mackram F. Eleid
Sunil Mankad
Paul Sorajja
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 1/2013
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-012-9311-5

Weitere Artikel der Ausgabe 1/2013

Heart Failure Reviews 1/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.